Immucell (ICCC) EBITDA Margin Growth (5y) (2015 - 2026)
Powered by 
Analysis
Immucell (ICCC) EBITDA Margin Growth (5y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.57 Bn | 40.38 Bn | 779.09 Mn |
| 2 | Zoetis | 30.57 Bn | 28.90 Bn | 1.05 Bn |
| 3 | Elanco Animal Health | 11.47 Bn | 10.94 Bn | 798.00 Mn |
| 4 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 134.40 Mn |
| 5 | Immucell | 87.38 Mn | 78.52 Mn | 2.44 Mn |
| 6 | Zhengye Biotechnology Holding | 64.40 Mn | 57.30 Mn | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2,218.00 |
| Dec 31, 2025 | 1,619.00 |
| Sep 30, 2025 | 712.00 |
| Jun 30, 2025 | 3,214.00 |
| Mar 31, 2025 | 984.00 |
| Dec 31, 2024 | 1,469.00 |
| Sep 30, 2024 | 491.00 |
| Jun 30, 2024 | -515.00 |
| Mar 31, 2024 | -1,015.00 |
| Sep 30, 2023 | -1,502.00 |
| Jun 30, 2023 | -3,051.00 |
| Mar 31, 2023 | -5,927.00 |
| Dec 31, 2022 | -2,858.00 |
| Sep 30, 2022 | 1,120.00 |
| Jun 30, 2022 | -87.00 |
| Mar 31, 2022 | -1,640.00 |
| Dec 31, 2021 | -272.00 |
| Sep 30, 2021 | 270.00 |
| Jun 30, 2021 | 384.00 |
| Mar 31, 2021 | -3,253.00 |